Sogroya Interactions
There are 438 drugs known to interact with Sogroya (somapacitan-beco), along with 8 disease interactions. Of the total drug interactions, 4 are major, 418 are moderate, and 16 are minor.
- View all 438 medications that may interact with Sogroya
- View Sogroya disease interactions (8)
Most frequently checked interactions
View interaction reports for Sogroya (somapacitan-beco) and the medicines listed below.
- acetaminophen
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- alprazolam
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- Amondys 45 (casimersen)
- Amvuttra (vutrisiran)
- anastrozole
- apremilast
- atorvastatin
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- azelastine / fluticasone nasal
- B Complex 100 (multivitamin)
- Bafiertam (monomethyl fumarate)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Eloctate (antihemophilic factor)
- Hemlibra (emicizumab)
- metformin
- Nurtec ODT (rimegepant)
- tadalafil
- testosterone
Sogroya disease interactions
There are 8 disease interactions with Sogroya (somapacitan-beco) which include:
- critical illness
- diabetes
- malignancies
- Prader-Willy syndrome
- hypoadrenalism
- hypothyroidism
- liver dysfunction
- scoliosis
Report options
More about Sogroya (somapacitan-beco)
- Sogroya consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: growth hormones
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Ngenla
Ngenla is a long-acting human growth hormone used to treat children aged 3 and older who are not ...
Humatrope
Humatrope injection (somatropin) is a human growth hormone used to treat growth failure in children ...
Skytrofa
Skytrofa injection is a once-weekly, slow-release human growth hormone (lonapegsomatropin) ...
Genotropin
Genotropin is a human growth hormone used to treat growth failure in children and adults who lack ...
Norditropin
Norditropin is used to treat growth hormone deficiency (GHD) in adults and children and other ...
Omnitrope
Omnitrope (somatropin) is a form of human growth hormone used to treat adults and children with ...
Norditropin FlexPro
Norditropin FlexPro is used for adult human growth hormone deficiency, idiopathic short stature ...
Zomacton
Zomacton is used for adult human growth hormone deficiency, idiopathic short stature, pediatric ...
Nutropin AQ
Nutropin AQ (somatropin) is an injectable preparation that may be used to treat children with ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
